Longtime Palantir shareholder who influenced host's initial purchase; writes investment thesis on Substack; focuses on Bezos/Amazon playbook pattern recognition — iteration culture, long-termism, talent density — as causal drivers of FCF/share compounding; applies framework across Duolingo, Hims & Hers, and Palantir.
Market overstates three claims: HIMS breaking law, management lacking strategy, FDA action being existential; in reality, team includes ex-Novo Nordisk COO and architects of FDA frameworks, and recent oral semaglutide launch reflects patient-centric innovation not desperation — comparable to Palantir suing US government pre-IPO.
Palantir's history — 3-person sales force, iconoclastic CEO, refusal to work with adversaries, mission-driven 'black box' culture — demonstrates that exceptional organizational traits (contrarianism, talent density, long-termism) predict directional outcomes even when specific products (AIP) cannot be forecast; same pattern now visible in Duolingo and HIMS.
Duolingo exhibits the same organizational traits as early Amazon — relentless experimentation, long-termism, and talent density — which are causally linked to exponential free cash flow per share growth; AI is an accelerant not a disruptor, evidenced by 150+ courses created in 2025 vs 100 in first 12 years, and FCF margin surging from 2.2% to 36.5% since LLM onset.